inprens

Morepen Laboratories Limited

NSE:MOREPENLAB   MOREPEN LABORATORI
PROS

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter
Company has delivered good profit growth of 41.36% CAGR over last 5 years
Promoter holding has increased by 3.84% over last quarter.

CONS

Stock is trading at 5.40 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。